Abstract:Ferroptosis induction through the suppression of glutathione peroxidase 4 (GPX4) and apoptosis-inducing factor mitochondria-associated 2 (AIFM2) has proven to be an effective approach in eliminating chemotherapy-resistant cells of various types. However, a comprehensive understanding of the roles of GPX4 and AIFM2 in acute myeloid leukemia (AML) has not yet been achieved. Using cBioPortal, DepMap, GEPIA, Metascape, and ONCOMINE, we compared the transcriptional expression, survival data, gene mutation, methylation, and network analyses of GPX4- and AIFM2-associated signaling pathways in AML. The results revealed that high expression levels of GPX4 and AIFM2 are associated with an adverse prognosis for AML patients. Overexpression of AIFM2 correlated with elevated mutation frequencies in NPM1 and DNMT3A. GPX4 upregulation modulated the following pathways: GO:0045333, cellular respiration; R-HSA-5389840, mitochondrial translation elongation; GO:0009060, aerobic respiration; R-HSA-9609507, protein localization; and R-HSA-8953854, metabolism of RNA. On the other hand, the overexpression of AIFM2 influenced the following processes: GO:0048704, embryonic skeletal system morphogenesis; GO:0021546, rhombomere development; GO:0009954, proximal/distal pattern formation; and GO:0048732, gland development. This study identifies the high expression of GPX4 and AIFM2 as novel biomarkers predicting a poor prognosis for AML patients. Furthermore, ferroptosis induction may improve the stratified treatment of AML.

Research Progress of Iron Metabolism and Ferroptosis in Myeloid Neoplasms

The Clinical Significance of Iron Overload and Iron Metabolism in Myelodysplastic Syndrome and Acute Myeloid Leukemia

The Ferroptosis Landscape in Acute Myeloid Leukemia.

Iron Metabolism, Ferroptosis, and Lncrna in Cancer: Knowns and Unknowns

Ferroptosis: Potential therapeutic targets and prognostic predictions for acute myeloid leukemia (Review)

Ferroptosis: Redox Imbalance and Hematological Tumorigenesis

Susceptibility of acute myeloid leukemia cells to ferroptosis and evasion strategies

Molecular Mechanisms of Ferroptosis and Its Roles in Hematologic Malignancies

Ferroptosis in lymphoma: Emerging mechanisms and a novel therapeutic approach

Iron and magnetic: new research direction of the ferroptosis-based cancer therapy.

A Promising Future of Ferroptosis in Tumor Therapy

Molecular Mechanisms of Ferroptosis and Updates of Ferroptosis Studies in Cancers and Leukemia

Ferroptosis: a new mechanism of traditional Chinese medicine for treating hematologic malignancies

Iron Metabolism in Ferroptosis

Potential applications of ferroptosis inducers and regulatory molecules in hematological malignancy therapy

Mechanisms of ferroptosis and targeted therapeutic approaches in urological malignancies

Iron Dysregulation in Human Cancer: Altered Metabolism, Biomarkers for Diagnosis, Prognosis, Monitoring and Rationale for Therapy

Ferroptosis and Tumor Drug Resistance: Current Status and Major Challenges

Metabolism-regulated ferroptosis in cancer progression and therapy

Ferroptosis and its emerging role in tumor

Iron Transporters and Ferroptosis in Malignant Brain Tumors